Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twinrix Immunogenicity and Risk Factors in Adults >40
NCT00289731Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2003
- Primary completion
- Dec 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis A (HAV), hepatitis B (HBV), sponsored by GSK. Started Nov 2003; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00289731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289731.